House Bill Would Set Deadline for FDA’s Final Rule on DTC Prescription Drug Ads

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

House Bill Would Set Deadline for FDA’s Final Rule on DTC Prescription Drug Ads

J.W. Schomisch

July 15, 2022 at 10:35 AM EST

A bill giving the FDA six months to finalize its amended regulations concerning direct-to-consumer (DTC) advertisements of prescription drugs was introduced in the House of Representatives July 7. The recently released spring 2022 Unified Agenda of Regulatory and Deregulatory Actions said the final rule was expected to be issued by next May. In last fall’s Unified Agenda the ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

House Bill Would Set Deadline for FDA’s Final Rule on DTC Prescription Drug Ads

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT